About Sparsh Nephrocare
Sparsh Nephrocare is a company based in Hyderabad (India) founded in 2011 was acquired by Fresenius Medical Care in September 2016. Sparsh Nephrocare has raised $3.32 million across 1 funding round from investors including Fresenius Medical Care and Tata Capital Healthcare Fund. Sparsh Nephrocare operates in a competitive market with competitors including NephroPlus, DCDC, Apex Kidney Care, VitusCare and The Renal Project, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$4.97 M (USD)5as on Mar 31, 2022
-
Net Profit
-$85.58 K (USD)89as on Mar 31, 2022
-
EBITDA
$596.45 K (USD)696as on Mar 31, 2022
-
Total Equity Funding
$3.32 M (USD)
in 1 rounds
-
Latest Funding Round
$3.32 M (USD), Series A
Mar 27, 2014
-
Investors
Fresenius Medical Care
& 1 more
-
Employee Count
Not available
-
Acquired by
Fresenius Medical Care
(Sep 02, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sparsh Nephrocare
Sparsh Nephrocare has successfully raised a total of $3.32M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.32 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sparsh Nephrocare
Sparsh Nephrocare has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Fresenius Medical Care and Tata Capital Healthcare Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund investing in healthcare and lifesciences in India.
|
Locked | Locked | Locked | |
|
Products and services for chronic kidney failure patients are developed.
|
Locked | Locked | Locked |
Investor details for Sparsh Nephrocare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sparsh Nephrocare
Investment portfolio details for Sparsh Nephrocare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sparsh Nephrocare
Detailed financials for Sparsh Nephrocare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sparsh Nephrocare Comparisons
Peer comparison for Sparsh Nephrocare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sparsh Nephrocare
Sparsh Nephrocare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NephroPlus, DCDC, Apex Kidney Care, VitusCare and The Renal Project, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Dialysis services and technician training are provided for kidney care.
|
|
| Locked | Locked | Locked |
Chain of dialysis and kidney clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
|
| Locked | Locked | Locked |
Chain of dialysis clinics
|
Detailed competitors of Sparsh Nephrocare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sparsh Nephrocare
Complete news archive for Sparsh Nephrocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sparsh Nephrocare
Sparsh Nephrocare was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Sparsh Nephrocare is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sparsh Nephrocare is a funded company, having raised a total of $3.32M across 1 funding round to date.
Annual revenue of Sparsh Nephrocare is $4.97M as on Mar 31, 2022.
Chain of dialysis clinics. Its offerings include home and hospital dialysis services. It focus is on improving accessibility and affordability of dialysis treatment for patients, especially in Tier II and Tier III locations.
Sparsh Nephrocare's top competitors include DCDC, Apex Kidney Care and NephroPlus.
Sparsh Nephrocare has 2 investors. Key investors include Fresenius Medical Care, and Tata Capital Healthcare Fund.